Verséa Health, Inc. is a transformative healthcare company committed to delivering innovative, high-value diagnostic and therapeutic point-of-care (POC), over-the-counter (OTC) and lab-based solutions across a broad range of diseases. Verséa Health takes a proactive approach in our current reactive healthcare system.
Founded in Q4 2018 by Sean Fetcho, Steve Porada and Colby Fox the company is led by experienced C-suite executives with growth and acquisition experience across multiple market segments and distribution channels. The leadership is supported by an Advisory Board that comprises of leading academic and multidisciplinary clinical medical advisors.
Leveraging its channel expertise and strategic industry partnerships the company has been successful in building long-term trusted relationships with thousands of healthcare providers (physicians, practices, laboratories, and large medical centers) and retail companies throughout the country.
We are also engaged in scientific research and discovery that enables, de-risks, and accelerates the assessment of potential new drug candidates for a myriad of human diseases.
Verséa Health, Inc. holds exclusive global licenses, 5 patents and several pending, private labeled brands, proprietary digital and capital equipment assets.
Our Product Portfolio consists of:
Our healthcare service solutions include:
Verséa has 4 strategic business units:
Each business unit provides unique value to the healthcare community and drives commercial success of Verséa.